Indications for Intravenous Hydrocortisone Administration
IV hydrocortisone should primarily be used in septic shock unresponsive to fluid resuscitation and vasopressors, adrenal insufficiency during surgery or acute illness, and acute severe asthma exacerbations requiring hospitalization. The appropriate use of IV hydrocortisone is guided by specific clinical scenarios where rapid glucocorticoid action is required.
Septic Shock
- IV hydrocortisone at 200 mg/day (continuous infusion or divided doses) is indicated when:
Adrenal Insufficiency in Perioperative Settings
For patients with known adrenal insufficiency undergoing surgery:
For patients on chronic steroid therapy (prednisolone ≥5 mg for ≥4 weeks):
Critical Illness-Related Corticosteroid Insufficiency (CIRCI)
- IV hydrocortisone <400 mg/day for ≥3 days at full dose is suggested for:
Acute Severe Asthma
- IV hydrocortisone can be used for acute severe asthma exacerbations requiring hospitalization
- Evidence shows similar efficacy compared to methylprednisolone and dexamethasone 2
- Initial dose of 100-500 mg IV, depending on severity 3
Administration Considerations
- Can be administered by IV injection, IV infusion, or IM injection
- For emergency use, IV injection is preferred 3
- When given as continuous infusion, hydrocortisone 200 mg/24h is recommended 1
- High-dose therapy should generally not continue beyond 48-72 hours 3
Important Caveats and Pitfalls
Adrenocorticotropic hormone (ACTH) stimulation testing is NOT recommended to identify patients who should receive hydrocortisone in septic shock 1
Hypernatremia risk: When high-dose hydrocortisone therapy continues beyond 48-72 hours, consider switching to methylprednisolone which causes less sodium retention 3
Tapering: After favorable response, determine maintenance dosage by decreasing initial dose in small decrements at appropriate intervals 3
Discontinuation: After long-term therapy, withdraw gradually rather than abruptly 3
Monitoring: No established biomarker exists for cortisol activity, so clinical response remains the primary monitoring parameter 4
By following these evidence-based guidelines for IV hydrocortisone administration, clinicians can optimize patient outcomes while minimizing potential adverse effects associated with inappropriate glucocorticoid use.